These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 8595159

  • 1. Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.
    Kievit E, Pinedo HM, Schlüper HM, Haisma HJ, Boven E.
    Br J Cancer; 1996 Feb; 73(4):457-64. PubMed ID: 8595159
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
    Molthoff CF, Pinedo HM, Schlüper HM, Nijman HW, Boven E.
    Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts.
    Kievit E, van Gog FB, Schlüper HM, van Dongen GA, Pinedo HM, Boven E.
    Int J Radiat Oncol Biol Phys; 1997 Jul 01; 38(4):813-23. PubMed ID: 9240651
    [Abstract] [Full Text] [Related]

  • 4. [186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer.
    Kievit E, van Gog FB, Schlüper HM, van Dongen GA, Pinedo HM, Boven E.
    Nucl Med Biol; 1998 Jan 01; 25(1):37-45. PubMed ID: 9466360
    [Abstract] [Full Text] [Related]

  • 5. Determination of tumor-related factors of influence on the uptake of the monoclonal antibody 323/A3 in experimental human ovarian cancer.
    Kievit E, Pinedo HM, Schlüper HM, Haisma HJ, Boven E.
    Int J Cancer; 1997 Apr 10; 71(2):237-45. PubMed ID: 9139849
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts.
    Molthoff CF, Pinedo HM, Schlüper HM, Rutgers DH, Boven E.
    Int J Cancer; 1992 Apr 22; 51(1):108-15. PubMed ID: 1563830
    [Abstract] [Full Text] [Related]

  • 7. Addition of cisplatin improves efficacy of 131I-labeled monoclonal antibody 323/A3 in experimental human ovarian cancer.
    Kievit E, Pinedo HM, Schlüper HM, Boven E.
    Int J Radiat Oncol Biol Phys; 1997 May 01; 38(2):419-28. PubMed ID: 9226331
    [Abstract] [Full Text] [Related]

  • 8. Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model.
    Velders MP, van Rhijn CM, Briaire IH, Fleuren GJ, Warnaar SO, Litvinov SV.
    Cancer Res; 1995 Oct 01; 55(19):4398-403. PubMed ID: 7671252
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and biodistribution of a new anti-episialin monoclonal antibody 139H2 in ovarian-cancer-bearing nude mice.
    Molthoff CF, Pinedo HM, Schlüper HM, Boven E.
    Cancer Immunol Immunother; 1991 Oct 01; 34(3):191-7. PubMed ID: 1756536
    [Abstract] [Full Text] [Related]

  • 10. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M, Schrijvers AH, van Walsum M, Braakhuis BJ, Quak JJ, Meijer CJ, Snow GB, van Dongen GA.
    Br J Cancer; 1992 Sep 01; 66(3):496-502. PubMed ID: 1520586
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
    Behr TM, Béhé M, Löhr M, Sgouros G, Angerstein C, Wehrmann E, Nebendahl K, Becker W.
    Eur J Nucl Med; 2000 Jul 01; 27(7):753-65. PubMed ID: 10952487
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
    Buchsbaum DJ, Brubaker PG, Hanna DE, Glatfelter AA, Terry VH, Guilbault DM, Steplewski Z.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):993s-999s. PubMed ID: 2297753
    [Abstract] [Full Text] [Related]

  • 14. Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapy.
    Leigh BR, Burke PA, Hong AM, O'Donnell RT, Howell LP, Miers LA, DeNardo GL, DeNardo SJ.
    Cancer Biother Radiopharm; 1999 Apr 01; 14(2):113-9. PubMed ID: 10850294
    [Abstract] [Full Text] [Related]

  • 15. Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy.
    Turner JH, Rose AH, Glancy RJ, Penhale WJ.
    Br J Cancer; 1998 Aug 01; 78(4):486-94. PubMed ID: 9716032
    [Abstract] [Full Text] [Related]

  • 16. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN.
    Visser GW, Klok RP, Gebbinck JW, ter Linden T, van Dongen GA, Molthoff CF.
    J Nucl Med; 2001 Mar 01; 42(3):509-19. PubMed ID: 11337531
    [Abstract] [Full Text] [Related]

  • 17. Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation.
    Kwa HB, Wesseling J, Verhoeven AH, van Zandwijk N, Hilkens J.
    Br J Cancer; 1996 Feb 01; 73(4):439-46. PubMed ID: 8595157
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J, Andersson H, Bäck T, Hultborn R, Jensen H, Karlsson B, Lindegren S, Palm S, Warnhammar E, Jacobsson L.
    J Nucl Med; 2005 Nov 01; 46(11):1907-15. PubMed ID: 16269606
    [Abstract] [Full Text] [Related]

  • 19. Experimental and clinical analysis of the characteristics of a chimeric monoclonal antibody, MOv18, reactive with an ovarian cancer-associated antigen.
    Molthoff CF, Buist MR, Kenemans P, Pinedo HM, Boven E.
    J Nucl Med; 1992 Nov 01; 33(11):2000-5. PubMed ID: 1432162
    [Abstract] [Full Text] [Related]

  • 20. Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroids.
    Langmuir VK, Mendonca HL, Woo DV.
    Cancer Res; 1992 Sep 01; 52(17):4728-34. PubMed ID: 1511438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.